Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Hambrecht & Quist Capital Management
AddedFeb 13, 2024
UpdatedJun 28, 2026
Hambrecht & Quist Capital Management

Hambrecht & Quist Capital Management

Operating

Tekla Capital Management, a Boston-based advisor, manages two equity funds focusing on healthcare and life sciences.

Location
Boston, MA, US
Founded
1968
Firm
Compare
Portfolio
Employees

Now known as Tekla Capital Management LLC. Hambrecht & Quist Capital Management, LLC (''HQCM''), a registered investment adviser based in Boston, Massachusetts, is currently the investment adviser for two closed-end equity funds, H&Q Healthcare Investors and H&Q Life Sciences Investors.

The Funds invest in growth equities, both public and private, in the healthcare and life sciences industries.

Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments9
Current Portfolio Count4
Total Portfolio Exits3

Top Investment Stages

Series C4 (44.4%)
Series Unknown3 (33.3%)
Series A1 (11.1%)
Series B1 (11.1%)

Stage Mix

Series C 44%Series Unknown 33%Series A 11%Series B 11%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Euthymics Bioscience logo

Euthymics Bioscience

Cardiokinetix logo

Cardiokinetix

Athersys logo

Athersys

InterPacket logo

InterPacket

Derivion logo

Derivion

Impresse logo

Impresse

Coppercom logo

Coppercom

Internap logo

Internap

Similar Investment Firms

Tekla Capital Management logo

Tekla Capital Management

abrdn.com

H&Q Healthcare Investors logo

H&Q Healthcare Investors

Questa Capital Management logo

Questa Capital Management

questacapital.com

Tekla Healthcare Investors logo

Tekla Healthcare Investors

abrdn.com

Hambrecht Healthcare Growth Venture Fund logo

Hambrecht Healthcare Growth Venture Fund

HLM Management logo

HLM Management

hlmvp.com

Fairmount Funds Management logo

Fairmount Funds Management

fairmountfunds.com

Hammer Capital Management logo

Hammer Capital Management

Hudson Structured Capital Management logo

Hudson Structured Capital Management

Cormorant Asset Management logo

Cormorant Asset Management

Amicus Capital Partners logo

Amicus Capital Partners

Sequoia Capital Global Equities logo

Sequoia Capital Global Equities

sequoiacap.com

Caxton Advantage Life Sciences Fund logo

Caxton Advantage Life Sciences Fund

Highbridge Capital Management logo

Highbridge Capital Management

Driehaus Capital Management logo

Driehaus Capital Management

driehaus.com

Hambrecht & Quist Capital Management - Classification

Also Known As
  • Tekla Capital Management LLC
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end
Show 2 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
SIC
  • 6000Depository Institutions